Any 0 3 0 3 O
patient 4 11 4 11 O
, 11 12 11 12 O
regardless 13 23 13 23 O
of 24 26 24 26 O
age 27 30 27 30 O
or 31 33 31 33 O
sex 34 37 34 37 O
, 37 38 37 38 O
with 39 43 39 43 O
a 44 45 44 45 O
diagnosis 46 55 46 55 O
of 56 58 56 58 O
EBV 59 62 59 62 B-chronic_disease
positive 63 71 63 71 O
Hodgkin 72 79 72 79 B-cancer
's 79 81 79 81 I-cancer
or 82 84 82 84 O
non 85 88 85 88 B-cancer
- 88 89 88 89 I-cancer
Hodgkin 89 96 89 96 I-cancer
's 96 98 96 98 I-cancer
Lymphoma 99 107 99 107 I-cancer
or 108 110 108 110 O
EBV 111 114 111 114 B-chronic_disease
( 115 116 115 116 I-chronic_disease
associated)-T 116 129 116 129 I-chronic_disease
/ 129 130 129 130 I-chronic_disease
NK 130 132 130 132 I-chronic_disease
- 132 133 132 133 I-chronic_disease
LPD 133 136 133 136 I-chronic_disease
lymphoproliferative 137 156 137 156 I-chronic_disease
disease 157 164 157 164 I-chronic_disease
or 165 167 165 167 O
Lymphoepithelioma 168 185 168 185 B-cancer
/ 185 186 185 186 O
leiomyosarcoma 186 200 186 200 B-cancer
regardless 201 211 201 211 O
of 212 214 212 214 O
histological 215 227 215 227 O
subtype 228 235 228 235 O
or 236 238 236 238 O
Severe 239 245 239 245 O
Chronic 246 253 246 253 B-chronic_disease
EBV 254 257 254 257 I-chronic_disease
and 258 261 258 261 O
in 262 264 262 264 O
remission 265 274 265 274 O
( 275 276 275 276 O
group 276 281 276 281 O
A 282 283 282 283 O
) 283 284 283 284 O
or 285 287 285 287 O
with 288 292 288 292 O
detectable 293 303 293 303 O
disease 304 311 304 311 O
( 312 313 312 313 O
group 313 318 313 318 O
B 319 320 319 320 O
) 320 321 320 321 O
after 322 327 322 327 O
allogeneic 328 338 328 338 B-treatment
SCT 339 342 339 342 I-treatment

Donor 0 5 343 348 O
HIV 6 9 349 352 B-chronic_disease
negative 10 18 353 361 O

Donors 0 6 362 368 O
who 7 10 369 372 O
are 11 14 373 376 O
HIV 15 18 377 380 B-chronic_disease
positive 19 27 381 389 O

Due 0 3 390 393 O
to 4 6 394 396 O
unknown 7 14 397 404 O
effects 15 22 405 412 O
of 23 25 413 415 O
this 26 30 416 420 O
therapy 31 38 421 428 B-treatment
on 39 41 429 431 O
a 42 43 432 433 O
fetus 44 49 434 439 O
, 49 50 439 440 O
pregnant 51 59 441 449 B-pregnancy
women 60 65 450 455 B-gender
are 66 69 456 459 O
excluded 70 78 460 468 O
from 79 83 469 473 O
this 84 88 474 478 O
research 89 97 479 487 O

Patients 0 8 488 496 O
should 9 15 497 503 O
have 16 20 504 508 O
been 21 25 509 513 O
off 26 29 514 517 O
other 30 35 518 523 B-treatment
investigational 36 51 524 539 I-treatment
therapy 52 59 540 547 I-treatment
for 60 63 548 551 O
one 64 67 552 555 B-upper_bound
month 68 73 556 561 I-upper_bound
prior 74 79 562 567 I-upper_bound
to 80 82 568 570 O
entry 83 88 571 576 O
in 89 91 577 579 O
this 92 96 580 584 O
study 97 102 585 590 O

Patients 0 8 591 599 O
with 9 13 600 604 O
GVHD 14 18 605 609 B-chronic_disease
> 19 20 610 611 O
Grade 21 26 612 617 B-lower_bound
II 27 29 618 620 I-lower_bound

Patients 0 8 621 629 O
with 9 13 630 634 O
a 14 15 635 636 O
Karnofsky 16 25 637 646 B-clinical_variable
/ 25 26 646 647 O
Lansky 26 32 647 653 B-clinical_variable
score 33 38 654 659 I-clinical_variable
of 39 41 660 662 O
> 42 43 663 664 O
50 44 46 665 667 B-lower_bound

Patients 0 8 668 676 O
with 9 13 677 681 O
a 14 15 682 683 O
creatinine 16 26 684 694 B-clinical_variable
< 27 28 695 696 O
2x 28 30 696 698 B-upper_bound
normal 31 37 699 705 I-upper_bound
for 38 41 706 709 O
age 42 45 710 713 B-age

Patients 0 8 714 722 O
with 9 13 723 727 O
bilirubin 14 23 728 737 B-clinical_variable
< 24 25 738 739 O
2x 25 27 739 741 B-upper_bound
normal 28 34 742 748 I-upper_bound
, 34 35 748 749 O
AST 36 39 750 753 B-clinical_variable
< 40 41 754 755 O
5x 41 43 755 757 B-upper_bound
normal 44 50 758 764 I-upper_bound
, 50 51 764 765 O
and 52 55 766 769 O
Hgb 56 59 770 773 B-clinical_variable
> 60 61 774 775 O
8.0 61 64 775 778 B-lower_bound

Patients 0 8 779 787 O
with 9 13 788 792 O
life 14 18 793 797 B-clinical_variable
expectancy 19 29 798 808 I-clinical_variable
> 30 31 809 810 O
6 32 33 811 812 B-lower_bound
weeks 34 39 813 818 I-lower_bound

Tumor 0 5 819 824 B-cancer
tissue 6 12 825 831 O
EBV 13 16 832 835 B-treatment
positive 17 25 836 844 O

must 0 4 845 849 O
not 5 8 850 853 O
have 9 13 854 858 O
less 14 18 859 863 O
than 19 23 864 868 O
50 24 26 869 871 B-upper_bound
% 26 27 871 872 I-upper_bound
donor 28 33 873 878 O
chimerism 34 43 879 888 O
in 44 46 889 891 O
either 47 53 892 898 O
peripheral 54 64 899 909 O
blood 65 70 910 915 O
or 71 73 916 918 O
bone 74 78 919 923 O
marrow 79 85 924 930 O

